Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Drabiak

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
The Journal of Legal Medicine|April 22, 2024
The Problem with Using Medical Boards to Regulate MisinformationKatherine Drabiak
Health Matrix (Cleveland, Ohio : 1991)|December 18, 2013
Challenging the FDA's authority to regulate autologous adult stem cells for therapeutic use: Celltex therapeutics' partnership with RNL Bio, substantial medical risks, and the implications of United States v. Regenerative SciencesKatherine Drabiak-Syed
Bioethics|January 17, 2020
The Nuffield Council's green light for genome editing human embryos defies fundamental human rights lawKatherine Drabiak
Journal of General Internal Medicine|November 12, 2025
Caution Is Warranted in Prescribing Ketamine for Mental HealthKatherine Drabiak
Bioethics|October 15, 2025
Three Roles for Clinical Ethicists to Provide Clarity and Guidance on Physician-Assisted Suicide/EuthanasiaKatherine Drabiak
Frontiers in Nuclear Medicine|October 2, 2024
Leveraging law and ethics to promote safe and reliable AI/ML in healthcareKatherine Drabiak
The American Journal of Bioethics : AJOB|January 18, 2011
Physicians prescribing "medicine" for enhancement: Why we should not and cannot overlook safety concernsKatherine Drabiak-Syed
AMA Journal of Ethics|March 30, 2020
What Should Health Care Organizations Do to Reduce Billing Fraud and Abuse?Katherine Drabiak, Jay Wolfson
Journal of Bioethical Inquiry|July 31, 2023
Eight Strategies to Engineer Acceptance of Human Germline ModificationsShoaib Khan, Katherine Drabiak
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|May 13, 2011
Reining in the pharmacological enhancement train: we should remain vigilant about regulatory standards for prescribing controlled substancesKatherine Drabiak-Syed
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
The Journal of Legal Medicine|April 22, 2024
The Problem with Using Medical Boards to Regulate MisinformationKatherine Drabiak
Health Matrix (Cleveland, Ohio : 1991)|December 18, 2013
Challenging the FDA's authority to regulate autologous adult stem cells for therapeutic use: Celltex therapeutics' partnership with RNL Bio, substantial medical risks, and the implications of United States v. Regenerative SciencesKatherine Drabiak-Syed
Bioethics|January 17, 2020
The Nuffield Council's green light for genome editing human embryos defies fundamental human rights lawKatherine Drabiak
Journal of General Internal Medicine|November 12, 2025
Caution Is Warranted in Prescribing Ketamine for Mental HealthKatherine Drabiak
Bioethics|October 15, 2025
Three Roles for Clinical Ethicists to Provide Clarity and Guidance on Physician-Assisted Suicide/EuthanasiaKatherine Drabiak
Frontiers in Nuclear Medicine|October 2, 2024
Leveraging law and ethics to promote safe and reliable AI/ML in healthcareKatherine Drabiak
The American Journal of Bioethics : AJOB|January 18, 2011
Physicians prescribing "medicine" for enhancement: Why we should not and cannot overlook safety concernsKatherine Drabiak-Syed
AMA Journal of Ethics|March 30, 2020
What Should Health Care Organizations Do to Reduce Billing Fraud and Abuse?Katherine Drabiak, Jay Wolfson
Journal of Bioethical Inquiry|July 31, 2023
Eight Strategies to Engineer Acceptance of Human Germline ModificationsShoaib Khan, Katherine Drabiak
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|May 13, 2011
Reining in the pharmacological enhancement train: we should remain vigilant about regulatory standards for prescribing controlled substancesKatherine Drabiak-Syed
Pageof 3